Atezolizumab

SEP 9, 2026 · PHASE 3 TRIAL

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

ClinicalTrials.gov

This is a clinical trial registry record for an active Phase 3 study with no results posted; the record describes planned design and enrollment only.

AUG 18, 2026 · PHASE 2 TRIAL

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

ClinicalTrials.gov

This is a Phase 2, single-arm feasibility study with no results yet posted; it is designed to evaluate concurrent SBRT and immunotherapy but carries no outcome data to assess efficacy or safety.

AUG 17, 2026 · PHASE 3 TRIAL

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

ClinicalTrials.gov

This is a Phase 3 RCT registration with no results posted; the study is actively recruiting and outcomes have not yet been reported.

AUG 14, 2026 · PHASE 3 TRIAL

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

ClinicalTrials.gov

This is a registered but actively recruiting Phase 3 trial with no results posted; the design is sound but evidence cannot yet be evaluated.

AUG 14, 2026 · PHASE 3 TRIAL

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

ClinicalTrials.gov

This is a Phase 3 trial registration with no results reported; the study is actively recruiting and outcome data are not yet available.

AUG 13, 2026 · PHASE 3 TRIAL

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.

AUG 11, 2026 · PHASE 1 TRIAL

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

ClinicalTrials.gov

Phase 1 dose-escalation study with planned enrollment of 24 participants; designed to establish safety and recommended Phase 2 dose, not to demonstrate efficacy or clinical benefit.

AUG 10, 2026 · PHASE 2 TRIAL

Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy

ClinicalTrials.gov

This is a Phase 2 pilot study registration with no reported results; it is designed to compare outcomes between performance status groups but enrollment and follow-up are ongoing.